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ABSTRACT Colistin (polymyxin E) is a last-resort antibiotic against multidrug-
resistant isolates of Pseudomonas aeruginosa. However, the nephro-toxicity of colistin
limits its use, spurring the interest in novel antimicrobial peptides (AMP). Here, we
show that the synthetic AMP-dendrimer G3KL (MW 4,531.38 Da, 15 positive charges,
MIC  8 mg/liter) showed faster killing than polymyxin B (Pmx-B) with no detectable
resistance selection in P. aeruginosa strain PA14. Spontaneous mutants selected on
Pmx-B, harboring loss of function mutations in the PhoQ sensor kinase gene,
showed increased Pmx-B MICs and arnB operon expression (4-amino-L-arabinose ad-
dition to lipid A), but remained susceptible to dendrimers. Two mutants carrying a
missense mutation in the periplasmic loop of the PmrB sensor kinase showed in-
creased MICs for Pmx-B (8-fold) and G3KL (4-fold) but not for the dendrimer T7 (MW
4,885.64 Da, 16 positive charges, MIC  8 mg/liter). The pmrB mutants showed in-
creased expression of the arnB operon as well as of the speD2-speE2-PA4775 operon,
located upstream of pmrAB, and involved in polyamine biosynthesis. Exogenous sup-
plementation with the polyamines spermine and norspermine increased G3KL and
T7 MICs in a phoQ mutant background but not in the PA14 wild type. This suggests
that both addition of 4-amino-L-arabinose and secretion of polyamines are required
to reduce susceptibility to dendrimers, probably neutralizing the negative charges
present on the lipid A and the 2-keto-3-deoxyoctulosonic acid (KDO) sugars of the li-
popolysaccharide (LPS), respectively. We further show by transcriptome analysis that
the dendrimers G3KL and T7 induce adaptive responses through the CprRS two-
component system in PA14.
KEYWORDS Pseudomonas aeruginosa, AMP-dendrimers, two-component systems,
antimicrobial peptides, dendrimers, two-component regulatory systems
Antimicrobial peptides (AMP) represent the most diverse class of antibiotics. Theyare synthesized by animals, plants, and microorganisms and show a broad spec-
trum of activity (1, 2). Their chemical structure includes linear peptides like LL-37, a
human AMP (3), or cyclic peptides like polymyxins produced by the bacterium Paeni-
bacillus polymyxa (4). The positively charged polymyxins interact with the negatively
charged phosphate residues of the lipid A, thereby displacing the Mg2 ions that
stabilize the lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria
(5–7). Subsequent insertion of the polymyxins into the lipid layer causes phospholipid
perturbations in both membranes, leading to osmotic imbalance and cell death.
Nonlytic AMPs may also have intracellular targets and can block cell division by
different mechanisms (8, 9). The most widely used AMP in the clinical setting is colistin
(polymyxin E), which has gained renewed interest because it is efficacious against
multidrug-resistant (MDR) Gram-negative bacteria (10–12).
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However, due to the toxicity of polymyxins (13, 14) and the emergence of resistance
against colistin in clinical settings, alternative AMPs are warranted (15–17). We recently
reported the synthesis of a group of dendrimer AMPs, characterized by a synthetic
branched-chain peptide scaffold consisting exclusively of D-Leu and D-Arg amino acid
residues (18–20). The dendrimer molecules tested here are characterized by MWs of
4,500 to 5,000 Da and present 15 to 17 positive charges at neutral pH. G3KL is a
representative of these third-generation dendrimers, which shows activity against MDR
Pseudomonas aeruginosa clinical isolates as well as Acinetobacter baumannii and Enter-
obacteriaceae harboring extended-spectrum -lactamases (ESBLs) (21, 22). G3KL has
low hemolytic activity, with minimal hemolytic concentrations above 2,000 g/ml (21)
and IC50 values around 1,000 g/ml for HeLa and CHO cells (23). G3KL and its deriva-
tives are synthesized with D-amino acids conferring increased stability against proteo-
lytic cleavage in the presence of human serum (21). Furthermore, G3KL was shown to
have an angiogenic effect on injured human fibroblast cells (24). G3KL-like dendrimers
are currently under preclinical development.
Since the physicochemical properties of the synthetic dendrimer antimicrobial
peptides differ substantially from natural AMPs like polymyxins, we wondered whether
dendrimers and polymyxins were affected by similar resistance mechanisms. Surpris-
ingly, attempts to select spontaneous mutants with G3KL were unsuccessful; however,
mutants selected on Pmx-B, harboring specific mutations in the PmrB sensor kinase,
showed decreased susceptibility to both G3KL and Pmx-B. We characterized these
mutants and found that two different mechanisms affecting the surface charge of the
LPS are required to achieve decreased susceptibility to G3KL.
RESULTS
Dendrimers have a low spontaneous resistance emergence frequency. G3KL
and T7 are representatives of third-generation dendrimer molecules (21). They differ in
their amino acid composition and molecular weight but have similar numbers of
positive charges (Fig. 1) and are active against P. aeruginosa reference strains and MDR
clinical isolates (MIC  8 mg/liter) (19). To evaluate the possibility of resistance emer-
gence to dendrimer AMPs, we attempted to select spontaneous mutants with P.
aeruginosa strain PA14 on agar plates using polymyxin B (Pmx-B) as a comparator (Fig.
1). While Pmx-R mutants appeared on Mueller-Hinton broth (MHB) agar plates at a
frequency of 107 to 108 on 2 or 4 the MIC, no colonies could be obtained at 2
or 4 the MIC with G3KL or T7 even after prolonged incubation (72 h). We thus
performed a selection in liquid medium in a microtiter plate format, exposing PA14 to
increasing G3KL and T7 concentrations. After six serial passages, we were still unable to
obtain a stable mutant showing increased MICs to G3KL, although such mutants
emerged readily with Pmx-B. However, one mutant colony (2P4) was obtained after six
passages with the dendrimer T7.
To investigate a potential cross-resistance between the different AMPs, we tested
colonies obtained during the initial Pmx-B selection on agar plates for their suscepti-
bilities to G3KL and T7. Among seventeen randomly selected colonies from the
Pmx-B-supplemented plates (4 the MIC of Pmx-B), fifteen were resistant to Pmx-B
alone (4.1 to 4.17) and only two colonies (4.18 and 4.19) showed increased MICs for
both Pmx-B and G3KL (Table S1 in the supplemental material). The single colony
selected on T7 showed decreased susceptibility to Pmx-B and to the other dendrimer
G3KL (Table 1). Hence, Pmx-B can select for mutants with decreased susceptibility to
G3KL. However, the dendrimers showed an extremely low resistance selection fre-
quency.
Cross-resistance between Pmx-B and dendrimers results from alterations in the
PmrB sensor kinase. One colony from each of the three resistance profiles (4.13, 4.18,
and 2P4) was submitted to whole-genome sequencing. Mutant 4.13, which is resistant
only to Pmx-B (MIC  8 mg/liter), showed a 4-nucleotide (nt) insertion at position 1,105,
resulting in a frameshift mutation at codon Val369 of PhoQ, a two-component system
(TCS) sensor kinase frequently mutated in colistin-resistant clinical isolates (Table 1 and
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Fig. 2) (25). The cross-resistant mutant 4.18, also selected on Pmx-B, showed a single
nucleotide change in the pmrB gene, encoding another TCS sensor kinase (26). This
mutation resulted in a Thr-to-Pro substitution at position 132, located in the periplas-
mic domain of PmrB (Fig. 2). The mutant obtained with the dendrimer T7 carried a
single nucleotide change in the pmrB gene, resulting in an Asp-to-Glu substitution at
position 47, also located in the periplasmic loop of PmrB (Table 1 and Fig. 2). Based on
these results, we sequenced the phoQ and pmrB genes in the remaining spontaneous
mutants selected on Pmx-B. Mutant colonies resistant only to Pmx-B showed alterations
in the phoQ gene resulting from deletions or short nucleotide insertions (Table S1). The
remaining colony displaying cross-resistance to Pmx-B and G3KL (4.19) carried a single
FIG 1 Chemical structures of dendrimers G3KL and T7 and polymyxin B. Dendrimers G3KL (MW 4,531.38 Da, 15 positive charges) and T7 (MW 4,885.64 Da, 16
positive charges) are representatives of third-generation AMP dendrimers. First, second, and third generation residues are indicated in orange, blue, and black
color, respectively. Polymyxin B was used as comparator (MW 1,301 Da, 5 positive charges).
TABLE 1 Susceptibilities and mutations of AMP-resistant mutants
Strain Selection
MIC (mg/liter)
Mutated gene Amino acid modificationPmx-B G3KL T7
PA14 none 1 8 8 wild-type none
4.13 Pmx-B 8 8 8 phoQ Val369fsa
4.18 Pmx-B 8 32 16 pmrB Thr132Proa
4.19 Pmx-B 8 32 16 pmrB Phe124Cys
2P4 T7 16 64 32 pmrB Asp47Glua
aMutations determined by whole-genome sequencing.
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nt change in pmrB, resulting in a Phe-to-Cys substitution at position 124, located again
in the periplasmic loop of PmrB (Table 1 and Fig. 2). We conclude that frameshift
mutations inactivating the PhoQ sensor kinase conferred resistance to Pmx-B only,
while specific amino acid substitutions occurring in the periplasmic loop of the sensor
kinase PmrB were required to confer decreased susceptibility to Pmx-B and the two
dendrimers.
G3KL preincubation protects against Pmx-B and dendrimer killing. To compare
the killing kinetics between dendrimers and Pmx-B, we performed time-kill assays with
the PA14 wild-type strain, the phoQ mutant 4.13, and the two pmrB mutants 4.18 and
2P4 at 6 the MIC of either Pmx-B or G3KL. Pmx-B caused a 2-log reduction in CFU after
24 h for the wild-type, while CFU of the phoQ and the two pmrB mutants remained
unaffected (Fig. 3a). In comparison, G3KL caused a faster killing than Pmx-B of PA14
cells, resulting in a final 6-log reduction of viable counts at 24 h. The phoQ mutant 4.13
showed a 2-log reduction in CFU after 24 h, while the CFU of the pmrB mutants 4.18 and
2P4 remained stable during 24 h (Fig. 3b).
To investigate, whether G3KL-mediated killing was affected by prior exposure to
AMPs, we precultured the PA14 wild type for 16 h in the presence of Pmx-B or G3KL at
0.25 the MIC. Preincubation by Pmx-B increased survival by 1 log or 2 log when
challenged subsequently with 6 the MIC of Pmx-B or G3KL, respectively (Fig. 3c). In
comparison, preincubation with G3KL increased the proportion of surviving PA14 cells
by 3 log or 4 log when challenged with Pmx-B or G3KL, respectively (Fig. 3d). The
cross-protection effect between Pmx-B and G3KL suggests the involvement of common
adaptive resistance mechanisms for both AMPs.
Role of lipid A modifications for Pmx-B and G3KL activity. PhoQ is the main
target for mutations leading to polymyxin resistance in P. aeruginosa clinical isolates
FIG 2 Mutations selected in the TCS sensor kinases PhoQ and PmrB. Mutations selected by Pmx-B are
shown by black dots, while the only mutation selected by T7 is shown in red (Table S1). Mutations
occurring in PhoQ are exclusively nonsense or frameshift mutations, leading to nonfunctional PhoQ
variants. These confer resistance to Pmx-B only. In contrast, mutations selected in PmrB are missense
mutations located in the periplasmic loop. These confer decreased susceptibility to Pmx-B and G3KL and
are likely gain-of-function mutations. The HAMP and histidine kinase domains are highlighted in blue and
yellow, respectively. TM, transmembrane segment; IM, inner membrane. Membrane topology predictions
were generated using OCTOPUS (http://octopus.cbr.su.se/).
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(25). The PhoPQ TCS regulates, among others, the expression of the arnBCADTEF
operon responsible for the synthesis of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and its
addition to the lipid A sugar portion of the LPS (27). We therefore measured the
expression of the arnB gene in PA14 and in the selected mutants 4.13, 4.18, 4.19, and
2P4 in the presence and the absence of G3KL. As shown in Fig. 4a, expression of arnB
was increased 17-fold compared to PA14 in the phoQ mutant 4.13, while in the pmrB
cross-resistant mutants (4.18, 4.19, and 2P4) arnB levels were increased 4- to 12-fold.
The expression of arnB was induced in the presence of 0.25 MIC of G3KL in the
wild-type strain as well as in the two cross-resistant mutants 4.18 and 4.19, but not in
mutant 2P4. This suggests that modification by the arn operon could affect suscepti-
bility to G3KL and T7. We therefore constructed a deletion in the arnT gene, encoding
the L-Ara4N transferase. In the PA14 wild type this resulted in a weak but reproducible
2-fold decrease in G3KL MICs, without affecting Pmx-B MICs (Table 2). Inactivation of
arnT in the phoQ mutant 4.13 resulted in a 4-fold decrease in Pmx-B MICs but had no
effect on G3KL MICs. Finally, when arnT was deleted in the cross-resistant mutant 4.18,
MICs for both AMPs decreased 4-fold (Table 2). These data suggest that addition of
L-Ara4N to the LPS affects susceptibility to G3KL. However, the expression level of the
arn operon did not correlate with the G3KL MICs, since in the phoQ mutant 4.13, which
showed the highest arnB expression, G3KL MICs were unaffected (Table 2). We there-
fore suspected that additional mechanisms might be required for decreased dendrimer
susceptibility.
Involvement of operon speD2-speE2-PA4775 in G3KL susceptibility. Since the
cross-resistant mutants carried mutations in the pmrB gene, we decided to measure
FIG 3 Killing challenge by Pmx-B and G3KL against wild-type PA14, the phoQ mutant 4.13, and the pmrB mutants 4.18 and 2P4. Killing assays were performed
with bacterial cell suspensions in M9 medium supplemented with 2 mM MgSO4 and 6 the MIC of either Pmx-B (6 mg/liter) or G3KL (48 mg/liter). (a) The phoQ
and pmrB mutants showed similar survival when challenged with Pmx-B. (b) In contrast, the pmrB mutants showed increased survival compared to the phoQ
mutant when challenged with G3KL. (c and d) Preincubation with either Pmx-B (c) or G3KL (d) increased the fraction of surviving cells upon subsequent
exposure to 6 the MIC of Pmx-B or G3KL. Killing curves were performed in technical triplicates and repeated on three separate occasions. Values are the mean
and standard deviations from one representative experiment.
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gene expression of the pmrAB operon as well as of the upstream genes speD2-speE2-
PA4775 (referred to as the speD2 operon), which have been reported to be regulated
by the PmrAB TCS (28). As expected, the expression of pmrB was increased in the pmrB
mutants 4.18, 4.19, and 2P4, suggesting a positive autoregulation loop, while in the
phoQ mutant 4.13, expression of pmrB was comparable to the PA14 wild-type strain
(Fig. 4b). G3KL caused a 5-fold induction of pmrB expression in mutant 4.18 bearing a
mutation in the periplasmic loop of PmrB. Expression of speD2 and speE2 showed at
least a 100-fold increase in the pmrB mutants, while in the phoQ mutant the expression
was comparable to that in PA14 (Fig. 4c and d). Preincubation of the strains with
subinhibitory concentrations of G3KL induced expression of speD2 and speE2 in PA14,
the phoQ mutant 4.13, and the pmrB mutant 4.18, but not in the pmrB mutants 4.19 and
2P4. This result strongly suggested an implication of the speD2 operon in decreased
susceptibility to dendrimers.
FIG 4 Expression analysis of arnB, pmrB, speD2, and speE2. genes by qPCR. Prior to RNA extraction,
bacterial strains were grown for 18 h in the presence or absence of 0.25 MIC of G3KL in MHB medium
in microtiter plates. Fold changes are calculated relative to PA14 without G3KL exposure. Results are the
mean and standard deviations of two independently performed experiments. The operon structure of
the speD2 operon and putative promoters (arrows) are shown below.
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Overexpression of polyamine synthesis operon increases G3KL resistance but
only in the phoQ mutant. The speD2 operon was previously shown to be involved in
the synthesis of polyamines (28, 29). We thus postulated that polyamines might play a
role in the decreased susceptibility of the pmrB mutants to G3KL. We therefore cloned
and expressed the three genes of this operon individually or in combination and
evaluated the effect on the activity of G3KL and Pmx-B. Plasmid-mediated expression
of the individual genes or pair of genes had no effect on G3KL MICs. However, we
observed an increase in G3KL MICs when the three genes were coexpressed in the
phoQ mutant 4.13 (4-fold increase in MICs), but not in the wild-type PA14 (Table 3 and
Table S2). In contrast, T7 MICs showed only a 2-fold increase when the three genes were
coexpressed in the phoQ mutant 4.13, suggesting that dendrimers do not have a
uniform behavior in response to LPS modifications. To confirm the role of the speD2
operon, we deleted by homologous recombination the speE2 gene in the pmrB mutants
4.18 and 4.19. Indeed the MICs of G3KL decreased for the 4.18 ΔspeE2 and 4.19 ΔspeE2
mutants relative to the PA14 wild-type strain, while the MICs of Pmx-B were not
affected (Table 3). This clearly demonstrates the specific role of the speD2 operon in the
decreased susceptibility to dendrimers in the cross-resistant mutants 4.18 and 4.19, and
suggests that polyamine synthesis is an essential determinant for the increased G3KL
MICs, but requires prior modification of lipid A by addition of L-Ara4N.
Externally added polyamines affect G3KL activity. P. aeruginosa and most Gram-
negative bacteria produce cadaverine, putrescine, and spermidine as the major poly-
amines (30). The polyamine synthesized by the speD2 operon has been suggested
recently to correspond to norspermidine (29). We therefore tested several commercially
available polyamines displaying various positively charged amines and carbon chain
lengths. We found that spermidine (C7H19N3) and norspermidine (C6H17N3), both carrying
three amine groups, had no effect on AMP MICs. Instead, we observed that spermidine
increased susceptibility to Pmx-B and G3KL by 2- to 4-fold, but only for the pmrB mutants
(underlined values in Table 4). In contrast, spermine (C10H26N4) and norspermine (C9H24N4),
both harboring four amine groups, increased MIC values of Pmx-B and G3KL in the phoQ
mutant 4.13 but not in the wild type (bold values in Table 4). Norspermine also increased




PA14 1 8 low
PA14 ΔarnT 1 4 ND
4.13 phoQ 8 8 high
4.13 phoQΔarnT 2 8 ND
4.18 pmrB 8 32 intermediate
4.18 pmrBΔarnT 2 8 ND
aND, not determined.




PA14 1 8 8
PA14 pIApX2 (vector) 1 8 8
PA14 pspDE2-5 1 16 8
4.13 8 16 8
4.13 pIApX2 (vector) 16 8 8
4.13 pspDE2-5 8 >64a 16
4.18 8 64 16
4.18 speE2 8 8 8
4.19 8 64 16
4.19 speE2 8 8 8
aValue in bold indicates  4-fold MIC increase compared to vector control.
AMP-Dendrimers in P. aeruginosa Antimicrobial Agents and Chemotherapy
April 2020 Volume 64 Issue 4 e02040-19 aac.asm.org 7









G3KL MICs in two of the three pmrB mutants (Table 4). These results are in agreement with
the hypothesis that endogenously synthesized polyamines are required for decreased
susceptibility to dendrimers.
Dendrimers induce arn and speD2 operon expression. To further investigate the
response of P. aeruginosa to Pmx-B and G3KL, we performed a transcriptome analysis
by RNA-seq of the PA14 wild type exposed to subinhibitory concentrations (0.25 the
MIC) of Pmx-B, G3KL, or T7. Overall, Pmx-B exposure resulted in a broader response
compared to dendrimers. Indeed, PA14 responded to Pmx-B by upregulating 73 and
downregulating 108 genes. In comparison, G3KL and T7 induced, respectively, upregu-
lation of 29 and 21 genes and downregulation of 18 and 27 genes (Tables S4, S5 and
S6). Not unexpectedly, genes that were upregulated by all three AMPs included the
complete arn operon genes as well as those of the speD2 operon (Table 5). Interestingly,
T7 showed the highest induction of the arn operon (8- to 12-fold change), while Pmx-B
and G3KL elicited a lower response (3- to 4-fold change). Expression of the speD2
operon was induced 4- to 15-fold by Pmx-B and T7 and only 3-fold by G3KL. As
expected from our quantitative real-time PCR (qPCR) data (Fig. 4b), expression of the
pmrAB genes, which regulate both arn and speD2 operons, were only marginally
upregulated by the AMPs. Interestingly, two other loci showed marked changes in gene
expression, namely, PA14_24360 (no homologue in PAO1), a gene located next to the
cprRS operon, and PA14_41280 (PA1797), located next to the parRS operon. While the
former was induced only by the dendrimers, the latter responded strongly (54-fold
TABLE 4 Effect of externally added polyamines on AMP activities
Strain Mutation
MIC (mg/liter) a,b
Pmx-B in presence of: G3KL in presence of:
No polyamine SpD nSpD SpN nSpN No polyamine SpD nSpD SpN nSpN
PA14 WT 1 0.5 1 1 1 8 4 8 16 16
4.13 phoQ 8 8 16 32 32 8 16 8 >64 >64
4.18 pmrB 8 2 8 4 8 32 8 32 32 >64
4.19 pmrB 8 2 8 4 8 32 8 64 32 >64
2P4 pmrB 16 8 8 8 8 64 16 64 32 64
aSpD, spermidine; nSpD, norspermidine; SpN, spermine; nSpN, norspermine (added at final conc. of 1 mM).
bMIC values in bold indicate at least a four-fold decrease in susceptibility; underlined MIC values indicate at least a four-fold increase in susceptibility.
TABLE 5 Gene expression profiling in response to AMPs in PA14
PA 14 locus Gene/locusa
Expression fold changeb
Pmx-B G3KL T7
PA14_18350 arnA 3.1 3.7 10.0
PA14_18370 arnB 2.1 3.4 8.1
PA14_18360 arnC 3.2 4.4 10.4
PA14_18340 arnD 3.3 3.7 11.1
PA14_18320 arnE 3.1 3.6 9.5
PA14_18310 arnF 3.4 3.2 10.1
PA14_18330 arnT 3.3 3.6 10.4
PA14_18300 ugd 3.8 3.9 11.5
PA14_04180 carO 4.6 2.6 5.5
PA14_44311 cprA 3.8 5.3 15.3
PA14_63110 speD2 13.7 2.9 8.1
PA14_63120 speE2 15.2 3.6 9.7
PA14_63130 PA4775 5.1 NC 3.9
PA14_24360 next cprRS 2.0 9.2 28.8
PA14_41280 next parRS 54.0 NC 2.2
PA14_38395 mexX 8.3 NC NC
PA14_38410 mexY 8.9 NC NC
PA14_63150 pmrA 2.6 NC 2.4
PA14_63160 pmrB 2.3 NC 2.2
aGenes in bold belong to the arn and spe operons.
bNC, no change.
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upregulation) to Pmx-B but not to the dendrimers (2-fold). We also observed an
8- to 9-fold induction by Pmx-B of the mexXY genes, encoding the MexXY efflux
pump involved in aminoglycoside export (31). Two other genes were induced by
the three AMPs: (i) the cprA gene, encoding a protein of unknown function
containing a short-chain dehydrogenase/isomerase domain (SDR) and shown to be
involved in Pmx-B resistance in P. aeruginosa strain PAK (32) and (ii) the carO gene,
encoding a periplasmic protein required for calcium homeostasis (33). In summary,
our transcriptomic data suggest that the same LPS-modification mechanisms are
expressed in response to the three AMPs as those overexpressed in the pmrB
mutants. However, Pmx-B seems to signal via the ParRS TCS, while the dendrimers
specifically induce the CprRS TCS (Fig. 5).
DISCUSSION
The purpose of this study was to unravel potential resistance mechanisms against
dendrimer AMPs, which differ in size, number of charges, and structure from the cyclic
polymyxins and linear antimicrobial peptides of mammalian origin. A major difference
was the difficulty in obtaining spontaneously resistant mutants with both dendrimers,
where we estimate the selection frequency with G3KL was at least 10- to 100-fold lower
than with Pmx-B. This might be due to faster killing of P. aeruginosa by G3KL compared
to Pmx-B, or to the requirement of specific mutations located in the periplasmic domain
of the PmrB sensor kinase gene. The fact that 20% of spontaneous mutants selected on
Pmx-B also showed decreased susceptibility to G3KL, but not to T7, indicates that only
partial cross-resistance exists between Pmx-B and certain dendrimers. Indeed, analysis
of additional dendrimer peptides revealed heterogeneity in their MICs for the selected
mutants (data not shown). All of the mutants resistant only to Pmx-B carried exclusively
loss-of-function mutations in the sensor kinase PhoQ of the PhoPQ two-component
FIG 5 Simplified scheme for the response of P. aeruginosa PA14 to G3KL and Pmx-B. Mutations leading to increased
Pmx-B MICs occurred either in PhoQ (loss-of-function mutations) or Pmr-B (likely gain-of-function mutations),
indicated by the star symbol. PhoQ mutations only affected arn operon expression without affecting pmrB
expression. In contrast, PmrB mutations increased both arn and speD2 operon expression (black arrows) (see Fig.
4). Adaptation to AMPs, according to RNA-seq experiments, likely occurs through induction of arn and speD2
operons via ParRS (Pmx-B) or CprRS (dendrimers) TCSs (see Table 5). Induction of these operons may occur either
directly (dashed gray lines) or through activation of pmrAB expression (not shown).
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system, as observed in polymyxin-resistant clinical isolates of P. aeruginosa (34–36).
These mutants are characterized by upregulation of the arnBCADTEF-ugd operon,
leading to addition of lipid A by L-4AraN (27). This modification alone, however, had no
effect on dendrimer susceptibilities. Only mutations that occurred more rarely in the
PmrB TCS sensor kinase also affected G3KL activities. Intriguingly, all mutations affect-
ing dendrimer MICs carried specific amino acid substitutions in the periplasmic loop of
PmrB, sensing the periplasmic concentration of divalent cations (Mg2 and Ca2) (26).
These mutations likely result in cation-independent activation of the PmrAB signaling
cascade leading to increased expression of one of its specific targets, namely the
operon speD2-speE2-PA4775, located upstream of pmrAB. Indeed, Mg2 ion starvation
was shown to strongly induce expression of the speD2 operon (28). The speD2 gene
encodes an S-adenosylmethionine decarboxylase and speE2, a putative spermidine
synthase. The protein encoded by PA4775 has no homologue within the databases but
the open reading frame (ORF) is cotranscribed with speE2 (28) and is required for
conferring resistance to dendrimers. Indeed, the speD2 operon was recently described
as being responsible for the synthesis of norspermidine (29, 37, 38). However, addition
of spermidine or norspermidine, carrying three amine groups, had no effect on AMP
activities. In contrast, spermine and norspermine, both harboring four amine groups,
increased Pmx-B and dendrimer MICs but only in a mutant overexpressing the arn
operon. Lipid A modification by L-Ara4N therefore seems to be a prerequisite for
polyamines to exert their protective effect. The exact site and type of interaction
between the polyamines and lipid A remains to be determined. L-Ara4N addition occurs
either on one or on both moieties of the D-glucosamine disaccharide of lipid A, leaving
two to three additional phosphate groups on the 2-keto-3-deoxyoctulosonic acid (KDO)
core sugars available for potential interactions with polyamines (39). The secreted
polyamines could stabilize the outer membrane under low Mg2 ion conditions and
thereby interfere with binding of positively charged antibiotics, including aminoglyco-
sides (29), polymyxins, and the dendrimers. The dendrimers are predicted to form a
globular structure with hydrophilic residues exposed to the exterior and the hydro-
phobic residues buried inside the molecule (21). Upon contact with a hydrophobic
environment, the structure would unfold to expose the hydrophobic residues for
interaction with the phospholipids of the outer membrane. We expect that the poly-
amines reduce initial binding of G3KL to the phosphates of the core LPS sugars, thereby
decreasing subsequent insertion into the lipid layer, unfolding, and translocation into
the periplasm.
Transcriptomic analysis and time-kill assays show that G3KL and T7 induce an
adaptive response in PA14 by increasing expression of the same gene products (arn
and speD2 operons) as those overexpressed in the pmrB mutants. However, the
response to G3KL was different between the three pmrB mutants. While the mutant
strains 4.18 (PmrB Thr132Pro) and 4.19 (PmrB Phe124Cys) still responded to G3KL, as
indicated by induction of the arnB gene, the PmrB D47E mutation present in mutant
2P4 resulted in constitutive high-level expression of arnB independent of G3KL (Fig. 4a).
The transcriptome analysis further suggests that the dendrimers trigger the CprRS TCS
while Pmx-B signals through the ParRS TCS, as described previously (31, 40) (Fig. 5).
CprRS is a peptide-responsive TCS, however, only linear peptides were tested and
included molecules with 3 to 7 positive charges and 7 to 34 amino acids (41). It is
therefore surprising that CprS also recognizes dendrimers, presenting 15 to 17 positive
charges and a branched-chain structure with 37 to 40 amino acids. This might be due
to the higher number of negative charges present in the periplasmic domain of CprS
(28 Asp/Glu residues, including a consecutive stretch of ten Asp/Glu), compared to
PmrB (19 Asp/Glu) and PhoQ (22 Asp/Glu), which are likely specialized in sensing
divalent cations (26).
In summary, peptide dendrimers are promising antimicrobial compounds with
variable structures and a low propensity for selection of resistance. Although P.
aeruginosa shows similar mechanisms involved in protection against dendrimers as for
polymyxins, the rapid killing observed with G3KL and the requirement for very specific
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pmrB mutations make them an interesting option for future development as novel
therapeutic agents against MDR Gram-negative bacteria.
MATERIALS AND METHODS
Bacterial strains, media, and chemicals. Bacterial strains and plasmids used in this study are shown
in Table 6. The primers used for qPCR analyses and construction of gene knockouts are listed in Table
S3. P. aeruginosa and Escherichia coli strains were grown in lysogeny broth (LB) at 37°C with agitation
(250 rpm). E. coli strain DH10B was used as a host for cloning experiments.
Dendrimers were synthesized and purified as described (19, 42). Polymyxin-B, polyamines, and
chemicals were purchased from Merck-Sigma (Switzerland).
Selection of mutants with decreased susceptibility to Pmx-B and dendrimers. Spontaneous P.
aeruginosa mutants resistant to polymyxin B (Pmx-B) were selected on Mueller-Hinton broth (MHB) agar
plates supplemented with 4 mg/liter of Pmx-B. An 150-L aliquot of P. aeruginosa culture grown in LB
medium was spread on these plates and incubated overnight at 37°C and then at room temperature until
the appearance of P. aeruginosa colonies.
Whole-genome sequencing. Genomic DNA was extracted using the DNeasy blood and tissue kit
(Qiagen) from bacterial strains grown in LB medium to midexponential phase (approximately to optical
density at 600 nm (OD600) of 1.0). DNA libraries were sequenced on an Illumina HiSeq instrument (100-bp
paired-end reads) at the iGE3 Genomics platform of the University of Geneva.
MIC determinations. MICs for all strains were determined in Mueller-Hinton broth (MHB) by broth
microdilution in accordance to the Clinical and Laboratory Standards Institute (CLSI) guidelines (43). AMP
concentrations ranged from 0.125 to 16 mg/liter (Pmx-B) and 0.5 to 64 mg/liter (G3KL and T7). MICs were
performed at least three times. Polyamines were dissolved in distilled water (dH2O) and added at the
indicated concentrations.
Killing kinetic assay. Bacteria were grown overnight in LB medium. For the Pmx-B and G3KL
preincubation, bacteria were grown with 0.25 MIC of the corresponding compound. Next, 500 l of
culture was centrifuged at 5,000 rpm for 3 min and pellets were resuspended in M9-salts medium and
adjusted to OD600  2.0. Fifteen microliters from these bacterial suspensions were added to the first row
of a microtiter plate containing 135 l of M9-salts medium (Na2HPO4 6 g/liter; KH2PO4 3 g/liter; NaCl 0.5
g/liter; NH4Cl 1 g/liter) supplemented with 2 mM MgSO4 and either 6 mg/liter of Pmx-B or 48 mg/liter of
G3KL. The microtiter plates were incubated at 37°C. At each time point (10 min, 30 min, 1 h, 4 h, and 24
h), serial dilutions were spotted in triplicate onto LB agar plates and CFU counts were determined after
incubation at 37°C.
RNA extraction. For RNA extraction, the strains were grown under MIC assay conditions in microtiter
plates in MH broth, supplemented or not with 0.25 the MIC of Pmx-B, G3KL, or T7. Three wells were
pooled to form one sample. RNA was extracted using the RNeasy minikit (Qiagen) according to the
manufacturer’s instructions. Genomic DNA was removed by treatment with RNase-free DNase (Promega).
TABLE 6 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source or reference
P. aeruginosa strains
PA14 wild-type (46)
4.13 PA14 phoQ 1105ins4bp, V369fs (Pmx-B selected) This study
4.18 PA14 pmrB 394AC, T132P (Pmx-B selected) This study
4.19 PA14 pmrB 371TG, F124C (Pmx-B selected) This study
2P4 PA14 pmrB A141G, D47E (T7 selected) This study
PA14 ΔarnT Unmarked deletion of arnT gene This study
4.13 ΔarnT Unmarked deletion of arnT gene This study
4.18 ΔarnT Unmarked deletion of arnT gene This study
4.18 ΔPAspeE2 Unmarked deletion of speE2 (PA4774) locus This study
4.19 ΔPAspeE2 Unmarked deletion of speE2 (PA4774) locus This study
E. coli strains
S17-1pir Strain used for conjugation (47)
DH10B F– endA1 deoR recA1 galE15 galK16 nupG rpsL Δ(lac)X74 80lacZΔM15
araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC), SmR, –
Lab collection
Plasmids
pEXG2 Suicide vector, Gm (48)
pIApX2 pUCP20 derivative, cloning vector with constitutive promoter; gfp; Ap I. Attree, France
pspD2 pIApX2 carrying speD2 gene from PA14 This study
pspE2 pIApX2 carrying speE2 gene from PA14 This study
pPA4775 pIApX2 carrying PA4775 gene from PA14 This study
pspDE2 pIApX2 carrying speD2 and speE2 genes from PA14 This study
pspE2-5 pIApX2 carrying speE2 and PA4775 genes from PA14 This study
pspDE2-5 pIApX2 carrying the speD2-speE2-PA4775 operon from PA14 This study
pΔarnT pExG2 derivative used to create arnT deletion mutant This study
pΔspE2 pExG2 derivative used to create speE2 deletion mutant This study
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Five hundred nanograms of RNA was reverse transcribed using ImProm-II reverse transcriptase (Pro-
mega).
Quantitative real-time PCR. Gene expression was measured using a Rotor-Gene SYBR Green PCR kit
(Qiagen), with primers specific to the genes of interest and the rpsL housekeeping gene (44). qPCRs were
performed in a Rotor-Gene 3000 (Corbett Research) with the following conditions: 5 min at 95°C, 5 sec
at 95°C, and 10 sec at 60°C (40 cycles). A melt-curve analysis was performed (60°C to 99°C) to confirm the
presence of a single amplification product.
RNA sequencing and bioinformatics analysis. Approximately 1.3 g of total RNA for each replicate
sample was ribodepleted using the Ribo-Zero rRNA removal kit for bacteria (Epicentre) according to the
manufacturer’s protocol. The TruSeq total RNA stranded kit (Illumina) was used for the preparation of
libraries. A Quibit spectrophotometer measured their quantity and a Tapestation on a DNA High-
sensitivity chip (Agilent Technologies) determined their quality. The 12 generated libraries were pooled
at equimolarity and loaded at 7 pM for clustering. An Illumina HiSeq 4000 instrument was used to
sequence 100-bp single reads per sample (iGE3 Genomics platform of the University of Geneva). FastQC
v.0.11.5 was used for sequencing quality control and reads were mapped to the NCBI NC_008463.1
Pseudomonas aeruginosa UCBP-PA14 reference genome using BWA aligner v.0.7.17 software. The counts
were normalized according to the relative number of reads for each library, and genes having a count
above 1 count per million reads (cpm) in at least 3 samples were kept for the analysis. The starting raw
gene number of the set was 6,100. The final filtered data set consisted of 6,043 genes after excluding
poorly or nonexpressed genes.
Construction of deletion mutants. The upstream and downstream flanking regions of the target
locus were PCR amplified (usually 500 to 600 bp) using primers with HindIII/BamHI or BamHI/EcoRI
restriction sites for the upstream and downstream flanking regions, respectively. DNA fragments were
ligated and inserted into the suicide vector pEXG2 (45) using HindIII and EcoRI restriction sites. Plasmid
constructs were transferred into the E. coli mobilizing strain S17-pir. After conjugation into P. aerugi-
nosa, mero-diploids were selected on M9-salts medium plates supplemented with citrate (20 mM) and
gentamicin (50 mg/liter). To select for recombinants which had lost the integrated plasmid, cell suspen-
sions were streaked on M9-salts agar plates supplemented with 20 mM citrate and 10% sucrose.
Sucrose-resistant and gentamicin-susceptible colonies were screened by PCR for the presence of the
expected deletion in the corresponding target gene. Two independent clones for each mutant were
selected for further analyses and frozen as glycerol stocks at 80 °C.
Construction of expression plasmids. The DNA regions with at least 60 nucleotides upstream of the
ATG initiation codon and downstream of the STOP codon were amplified by PCR from genomic DNA of
P. aeruginosa strain PA14. All primers contained BamHI and HindIII restriction sites. DNA fragments were
cloned into the expression vector pIApX2 (Table 6). Plasmid constructs were verified by Sanger sequenc-
ing. Plasmids were transferred into P. aeruginosa by electroporation and transformants were selected on
LB agar plates supplemented with 200 mg/liter of carbenicillin. Two independent colonies were chosen
for further analyses.
Availability of data and materials. The meta-data and raw data generated in this study are
available at GEO under the following series record: GSE139257.
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